TORONTO — CULT Food Science’s subsidiary Further Foods Inc. announced the launch of its Noochies! Sprinkles line of food toppers for dogs and cats. The toppers are designed to boost pets’ meals with ingredients that support digestion, nutrient absorption and immunity.
The toppers feature Bmmune™, the brand’s high-protein nutritional yeast, and Bflora™, the company’s probiotic blend of beneficial bacteria that supports immunity, gut health, digestion and more, according to the company. With options for both dogs and cats, the new line includes Immune Sprinkles, Joint Boost Sprinkles and Wellness Sprinkles.
“Noochies! is committed to providing dogs and cats with nutrition that’s not only good for them but also good for the planet,” said Mitchell Scott, chief executive officer of CULT Food Science. “Our Sprinkles do just that — offering delicious, plant-powered nutrition in a way that’s easy for pet parents to incorporate into their pets’ bowls.”
The Immune Sprinkles are designed to provide daily immunity support by delivering probiotics, prebiotics and postbiotics. Combined with Bmmune™ for immunity and vegan fermented glutamine, it can help reduce inflammation and support digestion and gut health, according to the company.
Formulated with animal-free cultured glucosamine, the Joint Boost Sprinkles are boosted with algae-derived DHA and turmeric to help reduce joint inflammation and Bmmune™ for a source of vitamin B.
The key ingredient of the Wellness Sprinkles is the Bflora™ probiotic blend, which is designed to create and maintain a healthy digestive tract, according to CULT. Blended with seaweed and fruit vegetable powders for antioxidants and phytonutrients, the goal is to provide a solution for gut health, skin and coat, and overall vitality.
The toppers will be available for customers in the United States and Canada beginning in October.
In addition to the launch of Noochies! Sprinkles, Further Foods also provided an update on its feeding trial with the US Food and Drug Administration (FDA). According to the company, the FDA has deemed its trial “generally appropriate” and requested additional details to ensure that the trial will adequately evaluate the safety of the cell-cultured chicken ingredient. The company expects to submit these details to the FDA in October.
Read more about new pet food and treat products.
